Detalhe da pesquisa
1.
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Lancet Oncol
; 24(7): 757-771, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329889
2.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Lancet Oncol
; 19(11): 1459-1467, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348537
3.
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.
J Clin Oncol
; 41(35): 5411-5421, 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639651
4.
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.
Eur J Cancer
; 107: 60-67, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30544060
5.
Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch.
Clin Pharmacokinet
; 55(2): 249-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446141
6.
Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
Cancer
; 107(2): 345-51, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16779792
7.
Brain metastases in patients with renal cell cancer receiving new targeted treatment.
J Clin Oncol
; 26(1): 152-4, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18165649